Skip to main content
Clinical Trials/NCT05333939
NCT05333939
Completed
Not Applicable

Investigating the Effect of Moringa Oleifera Leaf Powder on Breastmilk Quantity and Quality: a Double Blinded Randomized Placebo-controlled Trial

University of Kentucky1 site in 1 country41 target enrollmentStarted: May 17, 2022Last updated:
ConditionsBreastfeeding

Overview

Phase
Not Applicable
Status
Completed
Enrollment
41
Locations
1
Primary Endpoint
Milk output

Overview

Brief Summary

The overall objective is to obtain preliminary data on the effect of Moringa oleifera leaf supplementation (moringa) at 4g daily for four weeks compared to placebo to improve human milk quantity and quality and infant health. Hypothesis: Four grams of moringa daily by mouth compared to placebo will increase breastmilk output and percent of mother's own milk consumed by infant.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
0 Months to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Milk output

Time Frame: 7 days

24 hour milk output at 7 days

Secondary Outcomes

  • % mother's own milk consumed by infant(7 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Suzanna L Attia

Assistant Professor

University of Kentucky

Study Sites (1)

Loading locations...

Similar Trials